Nevro Corp (NVRO) Stock Volatility: Beta and Market Fluctuations

As of close of business last night, Nevro Corp’s stock clocked out at $15.64, up 2.22% from its previous closing price of $15.30. In other words, the price has increased by $+0.34 from its previous closing price. On the day, 735708 shares were traded. NVRO stock price reached its highest trading level at $16.12 during the session, while it also had its lowest trading level at $15.11.

Ratios:

To gain a deeper understanding of NVRO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.94 and its Current Ratio is at 6.37. In the meantime, Its Debt-to-Equity ratio is 0.76 whereas as Long-Term Debt/Eq ratio is at 0.74.

On January 12, 2024, RBC Capital Mkts Downgraded its rating to Sector Perform which previously was Outperform and also lowered its target price recommendation from $23 to $20.

Canaccord Genuity Downgraded its Buy to Hold on December 21, 2023, while the target price for the stock was maintained at $23.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 07 when McCormick Shawn bought 7,500 shares for $22.88 per share. The transaction valued at 171,633 led to the insider holds 26,866 shares of the business.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, NVRO now has a Market Capitalization of 569.26M and an Enterprise Value of 462.64M. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.33 while its Price-to-Book (P/B) ratio in mrq is 1.94. Its current Enterprise Value per Revenue stands at 1.09 whereas that against EBITDA is -5.91.

Stock Price History:

Over the past 52 weeks, NVRO has reached a high of $39.67, while it has fallen to a 52-week low of $13.98. The 50-Day Moving Average of the stock is 18.88, while the 200-Day Moving Average is calculated to be 20.48.

Shares Statistics:

It appears that NVRO traded 561.18K shares on average per day over the past three months and 481.15k shares per day over the past ten days. A total of 36.36M shares are outstanding, with a floating share count of 34.94M. Insiders hold about 3.65% of the company’s shares, while institutions hold 105.80% stake in the company. Shares short for NVRO as of Jan 31, 2024 were 4.6M with a Short Ratio of 8.20, compared to 4.59M on Dec 29, 2023. Therefore, it implies a Short% of Shares Outstanding of 12.69% and a Short% of Float of 21.24%.

Earnings Estimates

As of right now, 15 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$1.05 for the current quarter, with a high estimate of -$0.77 and a low estimate of -$1.26, while EPS last year was -$0.98. The consensus estimate for the next quarter is -$0.65, with high estimates of -$0.52 and low estimates of -$0.81.

Analysts are recommending an EPS of between -$2.19 and -$3.13 for the fiscal current year, implying an average EPS of -$2.65. EPS for the following year is -$2.21, with 17 analysts recommending between -$1.62 and -$2.79.

Revenue Estimates

In the current quarter, 16 analysts expect revenue to total $97.88M. It ranges from a high estimate of $98.46M to a low estimate of $97.18M. As of the current estimate, Nevro Corp’s year-ago sales were $95.18M, an estimated increase of 2.80% from the year-ago figure. For the next quarter, 16 analysts are estimating revenue of $111.22M, an increase of 2.20% less than the figure of $2.80% in the same quarter last year. There is a high estimate of $114.14M for the next quarter, whereas the lowest estimate is $107M.

A total of 18 analysts have provided revenue estimates for NVRO’s current fiscal year. The highest revenue estimate was $459.97M, while the lowest revenue estimate was $434.6M, resulting in an average revenue estimate of $441.88M. In the same quarter a year ago, actual revenue was $425.17M, up 3.90% from the average estimate. Based on 18 analysts’ estimates, the company’s revenue will be $469.05M in the next fiscal year. The high estimate is $502.14M and the low estimate is $456.3M. The average revenue growth estimate for next year is up 6.10% from the average revenue estimate for this year.

Most Popular

[the_ad id="945"]